MT Newswires6d agoneutral
Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires9d agoneutral
Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450MT Newswires9d agobullish
Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy RatingMT Newswires9d agoneutral
BNP Paribas Adjusts Price Target on West Pharmaceutical Services to $466 From $459MT Newswires9d agoneutral
Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $480 From $410GuruFocus.com10d agoneutral
West Pharmaceutical Services Inc (WST) (Q3 2026) Earnings Call Highlights: Record Margins, 36% ...Simply Wall St.49d agoneutral
Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)Simply Wall St.97d agoneutral
West Pharmaceutical Services (WST) Raised Guidance, Is The Upside Already Priced In?StockStory99d agoneutral
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings CallGuruFocus.com108d agoneutral
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ...StockStory108d agobullish
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock SoarsMT Newswires108d agoneutral
West Pharmaceutical Services Q2 Adjusted Earnings, Net Sales Rise; 2026 Outlook BoostedStockStory109d agoneutral
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For